文献速递胸部技术与安全CT

约克郡肺癌筛查试验中CT辐射剂量的评估

An evaluation of CT radiation doses within the Yorkshire Lung Screening Trial.
PubMed 文献 · Br J Radiol · 2024-01-01

该研究评估了肺癌筛查试验第一年所有低剂量CT扫描的辐射剂量,共3521次扫描,CTDIvol中位数1.1 mGy、DLP中位数42.4 mGycm、有效剂量中位数1.15 mSv;60-80kg参与者分别为1.0 mGy、35.8 mGycm、0.97 mSv。单次扫描的额外终生归因癌症风险范围为0.001%-0.006%。

要点

  • 3521次筛查扫描的CTDIvol中位数1.1 mGy、DLP中位数42.4 mGycm、有效剂量中位数1.15 mSv。
  • 60-80kg参与者CTDIvol中位数1.0 mGy、DLP中位数35.8 mGycm、有效剂量中位数0.97 mSv。
  • 单次扫描额外终生归因癌症风险范围为0.001%-0.006%。

核心结论

  • 使用经证实可提供高水平图像质量的扫描方案,可在典型肺癌筛查队列中实现低辐射剂量;观察到的剂量水平可被视为同类扫描仪、同等参与者队列肺癌筛查扫描的典型值。

研究设计与样本

  • 评估肺癌筛查试验第一年所有低剂量CT扫描的辐射剂量,纳入3521次扫描,记录辐射剂量指标、参与者身高、体重、性别和年龄。

诊断标准与关键数值

  • 3521次扫描的CTDIvol中位数1.1 mGy(IQR 0.70)、DLP中位数42.4 mGycm(IQR 24.9)、有效剂量中位数1.15 mSv(IQR 0.67)。
  • 60-80kg参与者的CTDIvol中位数1.0 mGy(IQR 0.30)、DLP中位数35.8 mGycm(IQR 11.4)、有效剂量中位数0.97 mSv(IQR 0.31)。
  • 男性CTDIvol与体重的相关性r=0.9123(P<.001),女性r=0.9052(P<.001);性别对CTDIvol的影响无统计学显著性(P=.2328)。
  • 单次扫描的额外终生归因癌症风险范围为0.001%-0.006%。

临床应用与阅片要点

  • 使用经证实可提供高水平图像质量的扫描方案,可在典型肺癌筛查队列中实现低辐射剂量。
  • 观察到的剂量水平可被视为同类扫描仪、同等参与者队列肺癌筛查扫描的典型值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate radiation doses for all low-dose CT scans performed during the first year of a lung screening trial.

METHODS: For all lung screening scans that were performed using a CT protocol that delivered image quality meeting the RSNA QIBA criteria, radiation dose metrics, participant height, weight, gender, and age were recorded. Values of volume CT dose index (CTDIvol) and dose length product (DLP) were evaluated as a function of weight in order to assess the performance of the scan protocol across the participant cohort. Calculated effective doses were used to establish the additional lifetime attributable cancer risks arising from trial scans.

RESULTS: Median values of CTDIvol, DLP, and effective dose (IQR) from the 3521 scans were 1.1 mGy (0.70), 42.4 mGycm (24.9), and 1.15 mSv (0.67), whilst for 60-80kg participants the values were 1.0 mGy (0.30), 35.8 mGycm (11.4), and 0.97 mSv (0.31). A statistically significant correlation between CTDIvol and weight was identified for males (r = 0.9123, P < .001) and females (r = 0.9052, P < .001), however, the effect of gender on CTDIvol was not statistically significant (P = .2328) despite notable differences existing at the extremes of the weight range. The additional lifetime attributable cancer risks from a single scan were in the range 0.001%-0.006%.

CONCLUSIONS: Low radiation doses can be achieved across a typical lung screening cohort using scan protocols that have been shown to deliver high levels of image quality. The observed dose levels may be considered as typical values for lung screening scans on similar types of scanners for an equivalent participant cohort.

ADVANCES IN KNOWLEDGE: Presentation of typical radiation dose levels for CT lung screening examinations in a large UK trial. Effective radiation doses can be of the order of 1 mSv for standard sized participants. Lifetime attributable cancer risks resulting from a single low-dose CT scan did not exceed 0.006%.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Iball GR, Beeching CE, Gabe R, et al. An evaluation of CT radiation doses within the Yorkshire Lung Screening Trial. Br J Radiol. 2024. PMID: 38308037. doi:10.1093/bjr/tqad045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。